Chang JY - Search Results

1

D-501036, a novel selenophene-based triheterocycle derivative, exhibits potent in vitro and in vivo antitumoral activity which involves DNA damage and ataxia telangiectasia-mutated nuclear protein kinase activation.

Juang SH, Lung CC, Hsu PC, Hsu KS, Li YC, Hong PC, Shiah HS, Kuo CC, Huang CW, Wang YC, Huang L, Chen TS, Chen SF, Fu KC, Hsu CL, Lin MJ, Chang CJ, Ashendel CL, Chan TC, Chou KM, Chang JY. Juang SH, et al. Among authors: chang jy, chang cj. Mol Cancer Ther. 2007 Jan;6(1):193-202. doi: 10.1158/1535-7163.MCT-06-0482. Mol Cancer Ther. 2007. PMID: 17237279

2

Novel mutation of topoisomerase I in rendering cells resistant to camptothecin.

Chang JY, Liu JF, Juang SH, Liu TW, Chen LT. Chang JY, et al. Cancer Res. 2002 Jul 1;62(13):3716-21. Cancer Res. 2002. PMID: 12097280

3

2,2'-Diphenyl-1-picrylhydrazyl radical-scavenging active components from adlay (Coix lachryma-jobi L. var. ma-yuen Stapf) hulls.

Kuo CC, Chiang W, Liu GP, Chien YL, Chang JY, Lee CK, Lo JM, Huang SL, Shih MC, Kuo YH. Kuo CC, et al. Among authors: chang jy. J Agric Food Chem. 2002 Oct 9;50(21):5850-5. doi: 10.1021/jf020391w. J Agric Food Chem. 2002. PMID: 12358449

4

A phase I study of weekly docetaxel, 24-hour infusion of high-dose fluorouracil/leucovorin and cisplatin in patients with advanced gastric cancer.

Chen LT, Liu TW, Wu CW, Chung TR, Shiah HS, Jan CM, Liu JM, Whang-Peng J, Chang JY. Chen LT, et al. Among authors: chang jy. Oncology. 2002;63(3):239-47. doi: 10.1159/000065471. Oncology. 2002. PMID: 12381903 Clinical Trial.

5

Salvinal, a novel microtubule inhibitor isolated from Salvia miltiorrhizae Bunge (Danshen), with antimitotic activity in multidrug-sensitive and -resistant human tumor cells.

Chang JY, Chang CY, Kuo CC, Chen LT, Wein YS, Kuo YH. Chang JY, et al. Among authors: chang cy. Mol Pharmacol. 2004 Jan;65(1):77-84. doi: 10.1124/mol.65.1.77. Mol Pharmacol. 2004. PMID: 14722239

6

Three new oleanane-type triterpenes from Ludwigia octovalvis with cytotoxic activity against two human cancer cell lines.

Chang CI, Kuo CC, Chang JY, Kuo YH. Chang CI, et al. Among authors: chang jy. J Nat Prod. 2004 Jan;67(1):91-3. doi: 10.1021/np030267m. J Nat Prod. 2004. PMID: 14738395

7

A novel bis-benzylidenecyclopentanone derivative, BPR0Y007, inducing a rapid caspase activation involving upregulation of Fas (CD95/APO-1) and wild-type p53 in human oral epidermoid carcinoma cells.

Juang SH, Pan WY, Kuo CC, Liou JP, Hung YM, Chen LT, Hsieh HP, Chang JY. Juang SH, et al. Among authors: chang jy. Biochem Pharmacol. 2004 Jul 15;68(2):293-303. doi: 10.1016/j.bcp.2004.03.036. Biochem Pharmacol. 2004. PMID: 15194001

8

BPR0L075, a novel synthetic indole compound with antimitotic activity in human cancer cells, exerts effective antitumoral activity in vivo.

Kuo CC, Hsieh HP, Pan WY, Chen CP, Liou JP, Lee SJ, Chang YL, Chen LT, Chen CT, Chang JY. Kuo CC, et al. Among authors: chang yl, chang jy. Cancer Res. 2004 Jul 1;64(13):4621-8. doi: 10.1158/0008-5472.CAN-03-3474. Cancer Res. 2004. PMID: 15231674

9

Four new 6-nor5(6-->7)abeo-abietane type diterpenes and antitumoral cytotoxic diterpene constituents from the bark of Taiwania cryptomerioides.

Chang CI, Chang JY, Kuo CC, Pan WY, Kuo YH. Chang CI, et al. Among authors: chang jy. Planta Med. 2005 Jan;71(1):72-6. doi: 10.1055/s-2005-837754. Planta Med. 2005. PMID: 15678377

10

Cytotoxic triterpenes from the aerial roots of Ficus microcarpa.

Chiang YM, Chang JY, Kuo CC, Chang CY, Kuo YH. Chiang YM, et al. Among authors: chang jy, chang cy. Phytochemistry. 2005 Feb;66(4):495-501. doi: 10.1016/j.phytochem.2004.12.026. Phytochemistry. 2005. PMID: 15694457

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,790 results

Search Page

Filters